Compound Evidence File
#EC-2026-0426
HMG
Filed under Peptides. The bureau holds 176 laboratory returns for this compound from 70 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
70 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Mar 2026 | 16 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 10.0 | 9.9 | 10.0 | 23 Apr 2026 | 25 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 9.9 | 10.0 | 28 Dec 2025 | 24 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 10.0 | 10.0 | 13 Jan 2026 | 12 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 9.9 | 10.0 | 27 Dec 2025 | 16 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 10.0 | 10.0 | 6 Jan 2026 | 5 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 12 Apr 2026 | 23 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Jan 2026 | 14 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 26 Feb 2026 | 2 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 15 Jul 2026 | 26 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 25 Mar 2026 | 7 Apr 2026 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 10.0 | 10.0 | 10.0 | 3 Jul 2025 | 3 Jul 2025 |
| Trusted PeptideCASE #VI-2026-0499 | X | 1 | 10.0 | 10.0 | 10.0 | 6 May 2025 | 6 May 2025 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 22 Mar 2026 | 3 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 4 Dec 2025 | 26 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 1 Apr 2026 | 18 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 9.9 | 17 May 2026 | 28 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 25 Feb 2026 | 25 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 9.9 | 9.9 | 10.0 | 2 Jan 2026 | 22 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 9.9 | 9.9 | 10.0 | 26 Nov 2025 | 24 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 10.0 | 16 Mar 2026 | 23 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 9.9 | 17 Feb 2026 | 2 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 20 Jan 2026 | 16 Jun 2026 |
| PurePeptidesCASE #VI-2026-0234 | X | 1 | 9.6 | 9.6 | 9.6 | 14 Jan 2025 | 14 Jan 2025 |
| Kits4lessCASE #VI-2026-0744 | X | 1 | 9.3 | 9.3 | 9.3 | 6 May 2025 | 6 May 2025 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 9.3 | 9.3 | 9.3 | 16 Mar 2025 | 16 Mar 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 8.9 | 8.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 8.8 | 8.8 | 8.8 | 20 Jun 2025 | 20 Jun 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.7 | 7.2 | 10.0 | 24 May 2026 | 24 May 2026 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 8.7 | 8.7 | 8.7 | 25 Apr 2025 | 25 Apr 2025 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 8.6 | 8.6 | 8.6 | 16 Mar 2025 | 16 Mar 2025 |
| Peptide HavenCASE #VI-2026-0898 | X | 1 | 8.6 | 8.6 | 8.6 | 2 Jul 2025 | 2 Jul 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.5 | 7.8 | 9.4 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.3 | 7.4 | 8.9 | 21 May 2026 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 4 | 8.2 | 6.5 | 10.0 | 24 May 2026 | 24 May 2026 |
| Peptide PartnersCASE #VI-2026-0295 | X | 4 | 8.2 | 6.7 | 10.0 | 11 Jun 2025 | 23 May 2026 |
| Mai PeptideCASE #VI-2026-0769 | X | 5 | 7.9 | 6.6 | 8.5 | 24 Apr 2025 | 25 May 2026 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 2 | 7.5 | 7.0 | 8.1 | 21 May 2025 | 20 May 2026 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 7.5 | 7.5 | 7.5 | 21 May 2025 | 21 May 2025 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 7.4 | 7.4 | 7.4 | 25 Apr 2025 | 25 Apr 2025 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 1 | 7.4 | 7.4 | 7.4 | 2 Apr 2025 | 2 Apr 2025 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 1 | 7.4 | 7.4 | 7.4 | 2 Apr 2025 | 2 Apr 2025 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | X | 1 | 7.3 | 7.3 | 7.3 | 6 May 2025 | 6 May 2025 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 1 | 7.3 | 7.3 | 7.3 | 2 Jul 2025 | 2 Jul 2025 |
| YimeiCASE #VI-2026-0081 | X | 4 | 7.1 | 5.5 | 9.2 | 7 May 2025 | 21 May 2026 |
| HXNetCASE #VI-2026-0061 | X | 7 | 7.0 | 5.7 | 8.7 | 27 Feb 2025 | 24 May 2026 |
| Alpha-GenCASE #VI-2026-0905 | X | 2 | 7.0 | 6.4 | 7.6 | 14 Jan 2025 | 26 Jan 2026 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 6.9 | 6.9 | 6.9 | 2 Jul 2025 | 2 Jul 2025 |
| Forever Young PharmacyCASE #VI-2026-0654 | X | 2 | 6.8 | 4.5 | 9.2 | 3 Jul 2025 | 21 May 2026 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 6.6 | 6.6 | 6.6 | 25 Apr 2025 | 25 Apr 2025 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 6.4 | 6.4 | 6.4 | 7 May 2025 | 7 May 2025 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 3 | 6.3 | 5.3 | 6.9 | 11 Jun 2025 | 20 May 2026 |
| ZhuoYan labCASE #VI-2026-0902 | X | 2 | 6.0 | 5.3 | 6.8 | 20 Jun 2025 | 25 May 2026 |
| Royal PeptidesCASE #VI-2026-0264 | X | 2 | 5.9 | 4.4 | 7.4 | 13 Feb 2025 | 17 May 2026 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 5.8 | 5.8 | 5.8 | 3 Jul 2025 | 3 Jul 2025 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 5.7 | 5.7 | 5.7 | 21 May 2025 | 21 May 2025 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 5.4 | 5.4 | 5.4 | 27 Feb 2025 | 27 Feb 2025 |
| Peptide CraftersCASE #VI-2026-0994 | X | 1 | 5.3 | 5.3 | 5.3 | 3 Jun 2025 | 3 Jun 2025 |
| Top PeptideCASE #VI-2026-0721 | X | 1 | 5.3 | 5.3 | 5.3 | 13 Feb 2025 | 13 Feb 2025 |
| Accelerate LabsCASE #VI-2026-0686 | X | 1 | 5.1 | 5.1 | 5.1 | 24 Apr 2025 | 24 Apr 2025 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 4.4 | 4.4 | 4.4 | 28 Mar 2025 | 28 Mar 2025 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | X | 1 | 4.4 | 4.4 | 4.4 | 2 Apr 2025 | 2 Apr 2025 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 4.3 | 4.3 | 4.3 | 20 Jun 2025 | 20 Jun 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 1 | 4.3 | 4.3 | 4.3 | 13 Feb 2025 | 13 Feb 2025 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 2.6 | 2.6 | 2.6 | 13 Feb 2025 | 13 Feb 2025 |
| SubQ SocietyCASE #VI-2026-0716 | X | 1 | 2.2 | 2.2 | 2.2 | 11 Jun 2025 | 11 Jun 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 1.1 | 1.1 | 1.1 | 2 Apr 2025 | 2 Apr 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 0.0 | 0.0 | 0.0 | 14 Jan 2025 | 14 Jan 2025 |
Open any subject to view the batch-level evidence for HMG alone.